Clinical Significance of IgG4 Serum Concentration in Graves’ Disease
Archivum Immunologiae et Therapiae Experimentalis · 2024
DOI: 10.2478/aite-2024-0015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archivum Immunologiae et Therapiae Experimentalis, 2024. Verfasst von Michal Olejarz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, Poznań, Poland. Hauptthemen laut MEDLINE: Immunoglobulin G, Graves Disease, Graves Ophthalmopathy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Elevated immunoglobulin G4 (IgG4) serum antibodies are an important feature of IgG4-related disease. However, IgG4 antibodies can play a role in autoimmune thyroid disorders. In this study, we aimed to evaluate the impact of serum IgG4 levels on clinical features of Graves’ disease (GD). We recruited 60 patients with GD (48 patients without thyroid eye disease, 12 patients with moderate-to-severe Graves’ orbitopathy [GO], and 25 healthy control subjects). The prevalence of high IgG4 serum concentration was 4.2% among GD patients without GO and 33.33% in patients with moderate-to-severe GO. The group with GO had significantly higher median IgG4 levels (87.9 mg/dL) than the control group (41.2 mg/dL, P = 0.034) and the GD without GO group (30.75 mg/dL, P < 0.001). Patients with thyroid nodules had lower IgG4 levels than patients without thyroid nodules, but the difference was not statistically significant (35.7 [24.8; 41.53] mg/dL vs. 43 [30.1; 92.7] mg/dL, P = 0.064). IgG4 as a diagnostic tool for moderate-to-severe GO had the following parameters: area under the curve (AUC): 0.851 ( P < 0.001), at the cut-off value of 49 mg/dL, negative predictive value: 100%, positive predictive value: 48%, sensitivity: 100%, specificity: 73%. There were no significant differences between the high and normal IgG4 groups in thyroid hormones, antithyroid antibodies, and ultrasound features. Serum IgG4 levels are associated with some of the clinical features of GD and can help in the diagnostic process of the disease. More research is needed to better understand the pathophysiology of IgG4 involvement in GD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, Poznań, Poland.
Zitieren
APA
Olejarz, M., Szczepanek-Parulska, E., Krygier, A., Wrotkowska, E., Sawicka-Gutaj, N., & Ruchala, M. (2024). Clinical Significance of IgG4 Serum Concentration in Graves’ Disease. Archivum Immunologiae et Therapiae Experimentalis. https://doi.org/10.2478/aite-2024-0015
Vancouver
Olejarz M, Szczepanek-Parulska E, Krygier A, Wrotkowska E, Sawicka-Gutaj N, Ruchala M. Clinical Significance of IgG4 Serum Concentration in Graves’ Disease. Archivum Immunologiae et Therapiae Experimentalis. 2024. doi:10.2478/aite-2024-0015
BibTeX
@article{Olejarz2024,
author = {Olejarz, Michal and Szczepanek-Parulska, Ewelina and Krygier, Aleksandra and Wrotkowska, Elzbieta and Sawicka-Gutaj, Nadia and Ruchala, Marek},
title = {Clinical Significance of IgG4 Serum Concentration in Graves’ Disease},
journal = {Archivum Immunologiae et Therapiae Experimentalis},
year = {2024},
doi = {10.2478/aite-2024-0015}
}
EUVIMED